Market research
3613.HK Beijing Tong Ren Tang Chinese Medicine Company Limited
HK HKD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 5B
- P/E ratio
- 13.53
- Analyst target
- 10.25
- Dividend yield
- 6.3%
- Beta
- 0.34
Community
Investor discussion
1 comment
Sign in to join the 3613.HK discussion.
5 years, 5 months ago
Beijing Tong Ren Tang Chinese Medicine Company Limited is currently in a long term uptrend where the price is trading 27.5% above its 200 day moving average.
From a valuation standpoint, the stock is 93.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.1.
Beijing Tong Ren Tang Chinese Medicine Company Limited's total revenue rose by 22.6% to $748M since the same quarter in the previous year.
Its net income has increased by 59.9% to $316M since the same quarter in the previous year.
Finally, its free cash flow fell by 76.1% to $27M since the same quarter in the previous year.
Based on the above factors, Beijing Tong Ren Tang Chinese Medicine Company Limited gets an overall score of 4/5.